0 Évaluations
ID

14835

Description

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT01423032

Lien

https://clinicaltrials.gov/show/NCT01423032

Mots-clés

Versions (1)
  1. 01/05/2016 01/05/2016 -
Téléchargé le

1 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Chronic Lymphocytic Leukemia NCT01423032

    Anglais

    Eligibility Chronic Lymphocytic Leukemia NCT01423032

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    histologically or immunologically confirmed chronic b-cell leukemia
    Description

    ID.1

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0023434
    UMLS CUI [1,2]
    C0019638
    refractory (i.e. no response or progression during initial chemotherapy) or relapsed situation after first-line treatment regimen
    Description

    ID.2

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0278791
    UMLS CUI [2]
    C0277556
    disease stage ii-iv according to rai or b/c according to binet staging system, respectively
    Description

    ID.3

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1511118
    UMLS CUI [2]
    C1514715
    eastern cooperative oncology group (ecog) performance status of 3 or better
    Description

    ID.4

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    negative pregnancy test/ adequate method of contraception
    Description

    ID.5

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0700589
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    t-cll, pll (prolymphocytic leukemia)
    Description

    ID.6

    Type de données

    boolean

    presence of richter's transformation
    Description

    ID.7

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0349631
    first-line treatment containing either fludarabine or bendamustine
    Description

    ID.8

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0059985
    UMLS CUI [2]
    C0525079
    acute infections or distinctly reduced organ function precluding the application of chemotherapy, as for pulmonary, heart, liver (total bilirubin > 5mg/dl), renal system (creatinine > 2 mg/dl), or metabolic disorders
    Description

    ID.9

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0275518
    UMLS CUI [2]
    C0025517
    UMLS CUI [3]
    C0678852
    secondary malignancy (except for curative treated basal cell carcinoma or cervical cancer)
    Description

    ID.10

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C3266877
    Retour au début de la page

    Similar models

    Eligibility Chronic Lymphocytic Leukemia NCT01423032

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    histologically or immunologically confirmed chronic b-cell leukemia
    boolean
    C0023434 (UMLS CUI [1,1])
    C0019638 (UMLS CUI [1,2])
    ID.2
    Item
    refractory (i.e. no response or progression during initial chemotherapy) or relapsed situation after first-line treatment regimen
    boolean
    C0278791 (UMLS CUI [1])
    C0277556 (UMLS CUI [2])
    ID.3
    Item
    disease stage ii-iv according to rai or b/c according to binet staging system, respectively
    boolean
    C1511118 (UMLS CUI [1])
    C1514715 (UMLS CUI [2])
    ID.4
    Item
    eastern cooperative oncology group (ecog) performance status of 3 or better
    boolean
    C1520224 (UMLS CUI [1])
    ID.5
    Item
    negative pregnancy test/ adequate method of contraception
    boolean
    C0032961 (UMLS CUI [1])
    C0700589 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    ID.6
    Item
    t-cll, pll (prolymphocytic leukemia)
    boolean
    ID.7
    Item
    presence of richter's transformation
    boolean
    C0349631 (UMLS CUI [1])
    ID.8
    Item
    first-line treatment containing either fludarabine or bendamustine
    boolean
    C0059985 (UMLS CUI [1])
    C0525079 (UMLS CUI [2])
    ID.9
    Item
    acute infections or distinctly reduced organ function precluding the application of chemotherapy, as for pulmonary, heart, liver (total bilirubin > 5mg/dl), renal system (creatinine > 2 mg/dl), or metabolic disorders
    boolean
    C0275518 (UMLS CUI [1])
    C0025517 (UMLS CUI [2])
    C0678852 (UMLS CUI [3])
    ID.10
    Item
    secondary malignancy (except for curative treated basal cell carcinoma or cervical cancer)
    boolean
    C3266877 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial